# Activated Charcoal Use in Chronic Kidney Disease Patients

> **NCT06906874** · PHASE2 · RECRUITING · sponsor: **Mansoura University** · enrollment: 40 (estimated)

## Conditions studied

- End Stage Renal Disease (ESRD)
- CKD 5D, Hemodialysis
- CKD-MBD - Chronic Kidney Disease Mineral and Bone Disorder

## Interventions

- **DRUG:** Activated Charcoal
- **DRUG:** Phosphate Binders

## Key facts

- **NCT ID:** NCT06906874
- **Lead sponsor:** Mansoura University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-08
- **Primary completion:** 2025-11
- **Final completion:** 2025-11
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2025-08-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06906874

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06906874, "Activated Charcoal Use in Chronic Kidney Disease Patients". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT06906874. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*